Cancer | Chr | Position | Mutation Type | dbSNP | Protein-change | Allele Freq | RBD |
---|---|---|---|---|---|---|---|
ACC | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
CESC | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
ESCA | |||||||
GBM | |||||||
HNSC | |||||||
HNSC | |||||||
HNSC | |||||||
KIRC | |||||||
KIRP | |||||||
LAML | |||||||
LGG | |||||||
LIHC | |||||||
LIHC | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUSC | |||||||
LUSC | |||||||
OV | |||||||
OV | |||||||
PRAD | |||||||
SARC | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
STAD | |||||||
STAD | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC |
Cancer | Type | Freq | Q-value |
---|---|---|---|
ACC | |||
CESC | |||
DLBC | |||
ESCA | |||
KIRC | |||
LUSC | |||
PAAD | |||
PCPG | |||
READ | |||
SARC | |||
SKCM | |||
TGCT |
Cancer | P-value | Q-value |
---|---|---|
KIRC | ||
MESO | ||
ACC | ||
KIRP | ||
COAD | ||
LAML | ||
GBM | ||
LIHC | ||
LGG | ||
UVM | ||
OV |
Transcript ID | Name | Length | RefSeq ID | Protein ID | Length | RefSeq ID | UniportKB ID |
---|---|---|---|---|---|---|---|
ENST00000445776 | PSMD4-205 | 703 | - | ENSP00000388089 | 193 (aa) | - | H0Y3Y9 |
ENST00000461434 | PSMD4-207 | 801 | - | - | - (aa) | - | - |
ENST00000469786 | PSMD4-209 | 408 | - | - | - (aa) | - | - |
ENST00000470396 | PSMD4-210 | 338 | - | - | - (aa) | - | - |
ENST00000453615 | PSMD4-206 | 371 | - | ENSP00000396633 | 84 (aa) | - | H0Y561 |
ENST00000368884 | PSMD4-202 | 1350 | XM_017001856 | ENSP00000357879 | 377 (aa) | XP_016857345 | P55036 |
ENST00000437736 | PSMD4-204 | 787 | - | ENSP00000414499 | 203 (aa) | - | A6PVX3 |
ENST00000427779 | PSMD4-203 | 649 | - | ENSP00000406408 | 39 (aa) | - | H7C2J9 |
ENST00000476855 | PSMD4-211 | 1232 | - | - | - (aa) | - | - |
ENST00000462970 | PSMD4-208 | 900 | - | - | - (aa) | - | - |
ENST00000491857 | PSMD4-212 | 461 | - | - | - (aa) | - | - |
ENST00000368881 | PSMD4-201 | 1333 | XM_006711464 | ENSP00000357876 | 380 (aa) | XP_006711527 | Q5VWC4 |
Ensembl ID | Gene Symbol | Coverage | Identiy | Ortholog | Gene Symbol | Coverage | Identiy | Species |
---|---|---|---|---|---|---|---|---|
ENSG00000159352 | PSMD4 | 100 | 100.000 | ENSMUSG00000005625 | Psmd4 | 97 | 96.458 | Mus_musculus |
ENSG00000159352 | PSMD4 | 99 | 48.131 | YHR200W | RPN10 | 88 | 50.424 | Saccharomyces_cerevisiae |
Go ID | Go_term | PubmedID | Evidence | Category |
---|---|---|---|---|
GO:0000165 | MAPK cascade | - | TAS | Process |
GO:0000209 | protein polyubiquitination | - | TAS | Process |
GO:0000502 | proteasome complex | 17323924. | IDA | Component |
GO:0002223 | stimulatory C-type lectin receptor signaling pathway | - | TAS | Process |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | - | TAS | Process |
GO:0003723 | RNA binding | 22658674. | HDA | Function |
GO:0005515 | protein binding | 10488153.11146632.15147878.16990800.17082820.17139257.17662948.18922472.19490896.19615732.19796170.19798103.20059542.20195357.24811749.25036637.26496610.29290612.29426014.29997244. | IPI | Function |
GO:0005634 | nucleus | 21873635. | IBA | Component |
GO:0005654 | nucleoplasm | - | IDA | Component |
GO:0005654 | nucleoplasm | - | TAS | Component |
GO:0005829 | cytosol | 21873635. | IBA | Component |
GO:0005829 | cytosol | - | IDA | Component |
GO:0005829 | cytosol | - | TAS | Component |
GO:0006521 | regulation of cellular amino acid metabolic process | - | TAS | Process |
GO:0008540 | proteasome regulatory particle, base subcomplex | 21873635. | IBA | Component |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | - | TAS | Process |
GO:0016579 | protein deubiquitination | - | TAS | Process |
GO:0022624 | proteasome accessory complex | - | ISS | Component |
GO:0031145 | anaphase-promoting complex-dependent catabolic process | - | TAS | Process |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | - | TAS | Process |
GO:0031593 | polyubiquitin modification-dependent protein binding | 21873635. | IBA | Function |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | - | TAS | Process |
GO:0038061 | NIK/NF-kappaB signaling | - | TAS | Process |
GO:0038095 | Fc-epsilon receptor signaling pathway | - | TAS | Process |
GO:0042802 | identical protein binding | 16990800.19931242. | IPI | Function |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 21873635. | IBA | Process |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | - | TAS | Process |
GO:0043248 | proteasome assembly | 21873635. | IBA | Process |
GO:0043488 | regulation of mRNA stability | - | TAS | Process |
GO:0043687 | post-translational protein modification | - | TAS | Process |
GO:0050852 | T cell receptor signaling pathway | - | TAS | Process |
GO:0055085 | transmembrane transport | - | TAS | Process |
GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | - | TAS | Process |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | - | TAS | Process |
GO:0070498 | interleukin-1-mediated signaling pathway | - | TAS | Process |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | - | TAS | Process |
GO:0090263 | positive regulation of canonical Wnt signaling pathway | - | TAS | Process |
GO:1901990 | regulation of mitotic cell cycle phase transition | - | TAS | Process |
GO:1902036 | regulation of hematopoietic stem cell differentiation | - | TAS | Process |